Quantitative Comparison of Direct Antibody Labeling and Tumor Pretargeting in Uveal Melanoma

Journal of Nuclear Medicine

Volumn 37, Issue 6, 1996, Pages 967-971

  Magnani, Patrizia ^b   Paganelli, Giovanni ^b   Modorati, Giulio ^b   Zito, Felicia ^b   Songini, Cristina ^b   Sudati, Francesco ^b   Koch, Peter ^b   Maecke, Helmut R ^b   Brancato, Rosario ^b   Siccardi, Antonio G ^b   Fazio, Ferruccio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

Avidin biotin; Monoclonal antibodies; SPECT; Uveal melanoma

Indexed keywords

AVIDIN; BIOTIN; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; TECHNETIUM;

ARTICLE; CHOROID TUMOR; COMPARATIVE STUDY; HUMAN; IMMUNOLOGY; MELANOMA; METHODOLOGY; RADIOIMMUNOASSAY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANTIBODIES, MONOCLONAL; AVIDIN; BIOTIN; CHOROID NEOPLASMS; HUMANS; MELANOMA; RADIOIMMUNODETECTION; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030160786     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bomanji J, Nimmon CC, Hungerford JL, Solanki K, Granowska M, Britton KE. Ocular radioimmunoscintigraphy: sensitivity and practical considerations. J Nucl Med 1988;29:1031-1044.
2. Larson SM. Biologic characterization of melanoma tumors by antigen specific targeting of radiolabeled anti-tumor antibodies. J Nucl Med 1991;32:287-291.
3. 2 fragments. Cancer Res 1985;45:3378-3387.
4. Bomanji J, Gamer A, Prasad J, et al. Characterization of ocular melanoma with cutaneous melanoma antibodies. Br J Ophthalmol 1987;71:647-650.
5. 99mTc-labeled cutaneous melanoma antibody fragments. Br J Ophthalmol 1987;71:651-658.
6. Scheidhauer K, Markl A, Leinsinger G, et al. Immunoscintigraphy in intraocular melanoma. Nucl Med Commun 1988;9:669-679.
7. Schaling DF, van der Pol JP, Jager MJ, van Kroonenburgh MJPG, Oosterhuis JA, Ruiter DJ. Radioimmunoscintigraphy and immunohistochemistry with melanoma-associated monoclonal antibodies in choroidal melanoma: a comparison of the clinical and immunohistochemical results. Br J Ophthalmol 1990;74:538-541.
8. Goodwin DA. Pharmacokinetics and antibodies. J Nucl Med 1987;28:1358-1362.
9. Messa C, Perani D, Lucignani G, et al. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET, J Nucl Med 1994;35:210-216.
10. Paganelli G, Magnani P, Zito F, et al. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res 1991;51:5960-5966.
11. Lucignani G, Paganelli G, Modorati G, et al. MRI, antibody-guided scintigraphy and glucose metabolism in uveal melanoma. J Comput Assist Tomogr 1992;16:77-83.
12. Koch P, Maecke HR. Technetium-99m-labeled biotin conjugate in a tumor pretargeting approach with monoclonal antibodies. Angewandte Chemie 1992;31:1507-1509.
13. Paganelli G, Pervez S, Siccardi AG, et al. Intraperitoneal radio-localization of tumors pretargeted by biotinylated monoclonal antibodies. Int J Cancer 1990;45:1184-1189.
14. Hnatowich DJ, Virzi F, Rusckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med 1987;28:1294-1302.
15. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;NS-25:638-643.
16. Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Scientific Publications; 1987:107-110.
17. Kessler RM, Ellis JR, Murray E. Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr 1984;8:514-522.
18. Seccamani E, Tattanelli M, Manani M, Spranzi E, Scassellati GA, Siccardi AG. A simple qualitative determination of human antibodies to murine immunoglobulins (HAMA) in serum samples. Nucl Med Biol 1989;2:167-170.
19. Shields JA. Current approaches to the diagnosis and management of choroidal melanomas. Surv Ophthalmol 1977;21:433-463.
20. Mafee MF, Peyman GA, Peace GH, Cohen SB, Mitchell MW. Magnetic resonance imaging in the evaluation and differentiation of uveal melanoma. Ophthalmology 1987;94:341-348.
21. Peyster RG, Augsburger JJ, Shields A, Hershey BL, Eagle R, Haskin ME. Intraocular tumors: evaluation with MR imaging. Radiology 1988;168:773-779.
22. The Collaborative Ocular Melanoma Study Group. Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study Group: COMS report 1. Arch Ophthalmol 1990;108:1268-1273.
23. Shields JA, Augsburger JJ, Brown GC, Stephens RF. The differential diagnosis of posterior uveal melanoma. Ophthalmology 1980;87:518-522.
24. Chang M, Zimmerman LE, McLean I. The persisting pseudomelanoma problem. Arch Ophthalmol 1984;102:726-727.
25. Shields JA, Shields CL. Current management of posterior uveal melanoma. Mayo Clin Proc 1993;68:1196-1200.
26. 99mTc]PnAO-biotin. Eur J Nucl Med 1994;21:314-321.
27. Dosio F, Magnani P, Paganelli G, Samuel A, Chiesa G, Fazio F. Three-step tumor pretargeting in lung cancer. J Nucl Biol Med 1994;37:228-233.
28. 2 fragments of monoclonal antibody 225.28S by a benign ocular nevus. Eur J Nucl Med 1988;14:165-166.
29. Scheidler J, Leinsinger G, Kirsch CM, Scheiffarth OF, Stefani FH, Riedel KG. Immunostaining of choroidal melanoma: assessment of its diagnostic accuracy and limitations in 101 cases. Br J Ophthalmol 1992;76:457-460.
30. Paganelli G, Magnani P, Siccardi AG, Fazio F. Applications of the avidin/biotin system for tumor targeting. In: Goldenberg D, ed. Cancer therapy with radiolabeled antibodies. Orlando: CRC Press; 1995:239-254.
31. Natali PG, Bigotti A, Cavaliere R, et al. Heterogeneous expression of melanoma-associated antigens and HLA antigens by primary and multiple metastatic lesions removed from patients with melanoma. Cancer Res 1985;45:2882-2889.
32. Matzku S, Kirchgessner H, Schmid U, Temponi M, Ferrone S. Melanoma targeting with a cocktail of monoclonal antibodies to distinct determinants of the human HMW-MAA. J Nucl Med 1989;30:390-397.
33. Schechter B, Silberman R, Arnon R, Wilchek M. Tissue distribution of avidin and streptavidin injected into mice: effect of avidin carbohydrate, streptavidin truncation and exogenous biotin. Eur J Biochem 1990;189:327-331.
34. 90Y-DOTA-biotin: initial evaluation [Abstract]. J Nucl Med 1993;34(suppl 5):94P.